Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion Pharma’s drive to reduce its reliance on cash cow Soliris has gone up a gear with a $855m offer for rare disease company Wilson Therapeutics. ... has a long way to go before it bears comparison with Soliris’$3.1bn turnover.

Alexion's Soliris gets US approval for myasthenia gravis

Alexion's Soliris gets US approval for myasthenia gravis Alexion's Soliris gets US approval for myasthenia gravis. New neurology indication could contribute $1.2bn to sales, says analysts. ... Alexion has finally claimed FDA approval for its complement inhibitor Soliris in myasthenia gravis (MG), potentially

Germany will be first EU launch market for new Soliris indication

Germany will be first EU launch market for new Soliris indication Soliris available that has demonstrated in clinical studies that it improves patients’symptoms and their ability to undertake daily activities.”. ... However, Soliris does come with a boxed warning of ‘life-threatening’and

NICE broadens access to Alexion's rare disease drug Strensiq

NICE broadens access to Alexion's rare disease drug Strensiq s reliance on its primary product Soliris (eculizumab), its $2.8bn treatment for atypical haemolytic uraemic syndrome (aHUS).

Result pages: 1 | 2 | 3 | 4 | 5 | 6 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics